相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies
Jordan Gauthier et al.
BLOOD (2021)
Next-Generation Pathology by Multiplexed Immunohistochemistry
Frederik De Smet et al.
TRENDS IN BIOCHEMICAL SCIENCES (2021)
Rapid single-molecule digital detection of protein biomarkers for continuous monitoring of systemic immune disorders
Yujing Song et al.
BLOOD (2021)
Cadherin 11 Promotes Immunosuppression and Extracellular Matrix Deposition to Support Growth of Pancreatic Tumors and Resistance to Gemcitabine in Mice
Ivana Peran et al.
GASTROENTEROLOGY (2021)
Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial
Stephan Kadauke et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
Nikhil C. Munshi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany
Nawid Albinger et al.
GENE THERAPY (2021)
Novel agents and regimens for hematological malignancies: recent updates from 2020 ASH annual meeting
Jing-Zhou Hou et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Targeting CD123 in hematologic malignancies: identifying suitable patients for targeted therapy
Mrinal M. Patnaik et al.
LEUKEMIA & LYMPHOMA (2021)
Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling
Evan W. Weber et al.
SCIENCE (2021)
Single-cell multiomics dissection of basal and antigen-specific activation states of CD19-targeted CAR T cells
Zhiliang Bai et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Mass Cytometry: a robust platform for the comprehensive immunomonitoring of CAR-T-cell therapies
Aurelien Corneau et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Blueprint for the discovery of biomarkers of toxicity and efficacy for CAR T cells and T-cell engagers
Sophie Paczesny et al.
BLOOD ADVANCES (2021)
Multiplex immunofluorescence staining and image analysis assay for diffuse large B cell lymphoma
Chung-Wein Lee et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2020)
Rapid and sensitive detection of interleukin-6 in serum via time-resolved lateral flow immunoassay
Dezhi Huang et al.
ANALYTICAL BIOCHEMISTRY (2020)
The single-cell pathology landscape of breast cancer
Hartland W. Jackson et al.
NATURE (2020)
Clonal kinetics and single-cell transcriptional profiling of CAR-T cells in patients undergoing CD19 CAR-T immunotherapy
Alyssa Sheih et al.
NATURE COMMUNICATIONS (2020)
High-dimensional immune-profiling in cancer: implications for immunotherapy
Samuel Chuah et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Outcomes of older patients in ZUMA-1, a pivotal study of axicabtagene ciloleucel in refractory large B-cell lymphoma
Sattva S. Neelapu et al.
BLOOD (2020)
New directions in chimeric antigen receptor T cell [CAR-T] therapy and related flow cytometry
Elena Maryamchik et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2020)
Multiplexed ion beam imaging (MIBI) for characterization of the tumor microenvironment across tumor types
Jason Ptacek et al.
LABORATORY INVESTIGATION (2020)
Mass Spectrometry Advances and Perspectives for the Characterization of Emerging Adoptive Cell Therapies
Camille Lombard-Banek et al.
MOLECULES (2020)
Human chimeric antigen receptor macrophages for cancer immunotherapy
Michael Klichinsky et al.
NATURE BIOTECHNOLOGY (2020)
Commercialanti-CD19 CART cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center
Pierre Sesques et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Rare osteosarcoma cell subpopulation protein array and profiling using imaging mass cytometry and bioinformatics analysis
Izhar S. Batth et al.
BMC CANCER (2020)
Current trends in cancer immunotherapy: a literature-mining analysis
Stamatia Pouliliou et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
The Chimeric Antigen Receptor Detection Toolkit
Yifei Hu et al.
FRONTIERS IN IMMUNOLOGY (2020)
Multiplex bioimaging of single-cell spatial profiles for precision cancer diagnostics and therapeutics
Mayar Allam et al.
NPJ PRECISION ONCOLOGY (2020)
Changes in Peripheral and Local Tumor Immunity after Neoadjuvant Chemotherapy Reshape Clinical Outcomes in Patients with Breast Cancer
Margaret L. Axelrod et al.
CLINICAL CANCER RESEARCH (2020)
OMIP-069: Forty-Color Full Spectrum Flow Cytometry Panel for Deep Immunophenotyping of Major Cell Subsets in Human Peripheral Blood
Lily M. Park et al.
CYTOMETRY PART A (2020)
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
Jeremy S. Abramson et al.
LANCET (2020)
Engineering better chimeric antigen receptor T cells
Hao Zhang et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2020)
SPATIAL SINGLE-CELL ANALYSIS OF COLORECTAL CANCER TUMOUR USING MULTIPLEXED IMAGING MASS CYTOMETRY
Minh Tran et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Hyperion imaging system reveals heterogeneous tumor microenvironment of oral squamous cell carcinoma patients at T1N0M0 stage
Shang Xie et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
A guide to cancer immunotherapy: from T cell basic science to clinical practice
Alex D. Waldman et al.
NATURE REVIEWS IMMUNOLOGY (2020)
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape
Mohamad Hamieh et al.
NATURE (2019)
Genome-wide analysis identifies NR4A1 as a key mediator of T cell dysfunction
Xindong Liu et al.
NATURE (2019)
Transcriptome-scale super-resolved imaging in tissues by RNA seqFISH
Chee-Huat Linus Eng et al.
NATURE (2019)
NR4A transcription factors limit CAR T cell function in solid tumours
Joyce Chen et al.
NATURE (2019)
An immunoproteomic approach to characterize the CAR interactome and signalosome
Maria C. Ramello et al.
SCIENCE SIGNALING (2019)
B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma
Adam D. Cohen et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
CD19 CAR T cell product and disease attributes predict leukemia remission durability
Olivia C. Finney et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion
Omar Khan et al.
NATURE (2019)
Immuno-SABER enables highly multiplexed and amplified protein imaging in tissues
Sinem K. Saka et al.
NATURE BIOTECHNOLOGY (2019)
Development of an IL-6 point-of-care assay: utility for real-time monitoring and management of cytokine release syndrome and sepsis
Saloumeh K. Fischer et al.
BIOANALYSIS (2019)
Potent Anti-Tumor Activity of Bcma CAR-T Therapy Against Heavily Treated Multiple Myeloma and Dynamics of Immune Cell Subsets Using Single-Cell Mass Cytometry
Yongxian Hu et al.
BLOOD (2019)
Engineered triple inhibitory receptor resistance improves anti-tumor CAR-T cell performance via CD56
Fan Zou et al.
NATURE COMMUNICATIONS (2019)
SIRPα expression delineates subsets of intratumoral monocyte/macrophages with different functional and prognostic impact in follicular lymphoma
Ya-Ping Chen et al.
BLOOD CANCER JOURNAL (2019)
MIBI-TOF: A multiplexed imaging platform relates cellular phenotypes and tissue structure
Leeat Keren et al.
SCIENCE ADVANCES (2019)
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
Daniel W. Lee et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Identification of Two CAR T-Cell Populations Associated with Complete Response or Progressive Disease in Adult Lymphoma Patients Treated with Axi-Cel
Zinaida Good et al.
BLOOD (2019)
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial
Frederick L. Locke et al.
LANCET ONCOLOGY (2019)
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Stephen J. Schuster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
y Clinical Proteomics for Post-Hematopoeitic Stem Cell Transplantation Outcomes
Sophie Paczesny et al.
PROTEOMICS CLINICAL APPLICATIONS (2019)
c-Jun overexpression in CAR T cells induces exhaustion resistance
Rachel C. Lynn et al.
NATURE (2019)
An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer
Steven Feins et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Chimeric antigen receptor T-cell therapy - assessment and management of toxicities
Sattva S. Neelapu et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Introduction to a review series on emerging immunotherapies for hematologic diseases
Sophie Paczesny et al.
BLOOD (2018)
Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL
John Rossi et al.
BLOOD (2018)
Translating anti-CD19 CAR T-cell therapy into clinical practice for relapsed/refractory diffuse large B-cell lymphoma
Victor A. Chow et al.
BLOOD (2018)
Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia
Miriam Y. Kim et al.
CELL (2018)
The expansion of targetable biomarkers for CAR T cell therapy
Michelle H. Townsend et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
Joseph A. Fraietta et al.
NATURE MEDICINE (2018)
CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade
Theodoros Giavridis et al.
NATURE MEDICINE (2018)
Interleukin-6: designing specific therapeutics for a complex cytokine
Christoph Garbers et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Chimeric Antigen Receptor Therapy
Carl H. June et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome
Robert Q. Le et al.
ONCOLOGIST (2018)
CAR T cell immunotherapy for human cancer
Carl H. June et al.
SCIENCE (2018)
Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia
Bianca D. Santomasso et al.
CANCER DISCOVERY (2018)
Cytokine release syndrome
Alexander Shimabukuro-Vornhagen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo
Sarwish Rafiq et al.
NATURE BIOTECHNOLOGY (2018)
Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels
James N. Kochenderfer et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Multiplexed ion beam imaging analysis for quantitation of protein expresssion in cancer tissue sections
Sandra Rost et al.
LABORATORY INVESTIGATION (2017)
Simultaneous epitope and transcriptome measurement in single cells
Marlon Stoeckius et al.
NATURE METHODS (2017)
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
S. S. Neelapu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
TCR engagement negatively affects CD8 but not CD4 CAR T cell expansion and leukemic clearance
Yinmeng Yang et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Synergistic IL-6 and IL-8 paracrine signalling pathway infers a strategy to inhibit tumour cell migration
Hasini Jayatilaka et al.
NATURE COMMUNICATIONS (2017)
Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
Juliane Gust et al.
CANCER DISCOVERY (2017)
CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
Levi J. Rupp et al.
SCIENTIFIC REPORTS (2017)
High-throughput flow cytometry for drug discovery: principles, applications, and case studies
Mei Ding et al.
DRUG DISCOVERY TODAY (2017)
Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy
Kevin A. Hay et al.
BLOOD (2017)
The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity
Fiona C. Thistlethwaite et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia
Julie C. Fitzgerald et al.
CRITICAL CARE MEDICINE (2017)
Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignancies
Marianna Sabatino et al.
BLOOD (2016)
Single-Cell Phosphoproteomics Resolves Adaptive Signaling Dynamics and Informs Targeted Combination Therapy in Glioblastoma
Wei Wei et al.
CANCER CELL (2016)
Immunotherapeutic implications of IL-6 blockade for cytokine storm
Toshio Tanaka et al.
IMMUNOTHERAPY (2016)
CD19 CAR-T cells of defined CD4+: CD8+ composition in adult B cell ALL patients
Cameron J. Turtle et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy
Hanren Dai et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Immunotherapy of non-Hodgkin's lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells
Cameron J. Turtle et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia
David T. Teachey et al.
CANCER DISCOVERY (2016)
Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy
Hanren Dai et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
Daniel W. Lee et al.
LANCET (2015)
Highly multiplexed profiling of single-cell effector functions reveals deep functional heterogeneity in response to pathogenic ligands
Yao Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
David L. Porter et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Highly multiplexed imaging of single cells using a high-throughput cyclic immunofluorescence method
Jia-Ren Lin et al.
NATURE COMMUNICATIONS (2015)
T-cell-based Immunotherapy: Adoptive Cell Transfer and Checkpoint Inhibition
Roch Houot et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15
Yang Xu et al.
BLOOD (2014)
Current concepts in the diagnosis and management of cytokine release syndrome
Daniel W. Lee et al.
BLOOD (2014)
Multiplexed ion beam imaging of human breast tumors
Michael Angelo et al.
NATURE MEDICINE (2014)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Cell Surface Profiling Using High-Throughput Flow Cytometry: A Platform for Biomarker Discovery and Analysis of Cellular Heterogeneity
Craig A. Gedye et al.
PLOS ONE (2014)
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
Marco L. Davila et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells
Liza B. John et al.
CLINICAL CANCER RESEARCH (2013)
Chimeric Antigen Receptor-Modified T Cells for Acute Lymphoid Leukemia
Stephan A. Grupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
Renier J. Brentjens et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Multifunctional T-cell Analyses to Study Response and Progression in Adoptive Cell Transfer Immunotherapy
Chao Ma et al.
CANCER DISCOVERY (2013)
Multiparameter Flow Cytometry: Advances in High Resolution Analysis
Erika A O'Donnell et al.
Immune Network (2013)
New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer
David F. Stroncek et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Ultra High Resolution Linear Ion Trap Orbitrap Mass Spectrometer (Orbitrap Elite) Facilitates Top Down LC MS/MS and Versatile Peptide Fragmentation Modes
Annette Michalski et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
Renier J. Brentjens et al.
BLOOD (2011)
Interleukin-6, a mental cytokine
Anneleen Spooren et al.
BRAIN RESEARCH REVIEWS (2011)
A clinical microchip for evaluation of single immune cells reveals high functional heterogeneity in phenotypically similar T cells
Chao Ma et al.
NATURE MEDICINE (2011)
A human memory T cell subset with stem cell-like properties
Luca Gattinoni et al.
NATURE MEDICINE (2011)
Polychromatic flow cytometry in the clinical laboratory
William A. Sewell et al.
PATHOLOGY (2011)
Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
Sean C. Bendall et al.
SCIENCE (2011)
Establishment and validation of a standard protocol for the detection of minimal residual disease in B lineage childhood acute lymphoblastic leukemia by flow cytometry in a multi-center setting
Julie Irving et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Stem cell-like plasticity of naive and distinct memory CD8+ T cell subsets
Christian Stemberger et al.
SEMINARS IN IMMUNOLOGY (2009)
Interleukin-6 serum level assessment using a new qualitative point-of-care test in sepsis: A comparison with ELISA measurements
Joerg C. Schefold et al.
CLINICAL BIOCHEMISTRY (2008)
Adoptive transfer of effector CD8(+) T cells derived from central memory cells establishes persistent T cell memory in primates
Carolina Berger et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
T-cell quality in memory and protection: implications for vaccine design
Robert A. Seder et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Comparative analysis of flow cytometry and polymerase chain reaction for the detection of minimal residual disease in childhood acute lymphoblastic leukemia
GAM Neale et al.
LEUKEMIA (2004)
分享论文
